WHO estimates that in 2015, 257 million people were living with chronic hepatitis B virus
(HBV) infection worldwide, and that 900 000 had died from HBV infection, mostly as a result …

Hepatitis B virus (HBV) infection is the commonest cause of chronic hepatitis, with an
estimated global prevalence of 3.5%, and which leads to significant morbidity and mortality …

Hepatitis B virus (HBV) infection, the most common form of chronic hepatitis worldwide, is a
major public health problem affecting an estimated 360 million people globally. Mother-to …

Chronic HBV infection is estimated to affect> 350 million people worldwide and represents a
substantial source of morbidity and mortality related to cirrhosis and hepatocellular …

Chronic hepatitis B virus (HBV) infection due to mother-to-child transmission (MTCT) during
perinatal period remains an important global health problem. Despite standard passive …

Hepatitis B during pregnancy presents unique management issues for both the mother and
fetus. These include the lack of a current cohesive strategy for treatment and follow-up of …

Hepatitis B infection during pregnancy presents a unique set of management issues.
Aspects of care that must be considered include maternal and fetal effects of hepatitis B …

Chronic hepatitis B virus (HBV) infection affects about 350 million individuals worldwide.
Management of HBV infection in pregnancy is difficult because of several peculiar and …

During 2016–2020, global coverage with the third dose of hepatitis B vaccine remained
between 82% and 85%, whereas timely coverage with hepatitis B birth dose increased from …

BACKGROUND & AIMS: Despite immunoprophylaxis, mother to child transmission (MTCT)
of hepatitis B virus (HBV) still occurs in infants born to hepatitis B surface antigen (HBsAg) …